{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:25:05Z","timestamp":1790425505396,"version":"4.1.0"},"reference-count":47,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Today's pharmaceutical products are seeing a massive increase in impurity profiling.\nA drug substance or product will inevitably contain contaminants in trace amounts. According\nto pharmaceutical chemistry, impurities are undesirable substances found in pharmaceutical\ncompounds with therapeutic activity. Due to their extraordinary potency and likelihood of toxicity,\nthey may exhibit unanticipated pharmacological effects that are detrimental to human\nhealth. For the pharmaceutical sector, impurity management is currently a major concern. The\nimpurity can appear in medicines either during the formulation process or after the produced\nActive Pharmaceutical Ingredients (APIs) have aged. The term \"impurity profiling\" refers to a\ncollection of analytical procedures that include characterizing, quantifying, and describing the\nknown and unknown impurities found in novel pharmacological compounds. Highly sophisticated\nanalytical techniques and instrumentation are essential for identifying small elements\n(drugs, contaminants, breakdown products, and metabolites) in diverse matrices. Current references\nand articles reveal different impurities found in the APIs of antiviral drugs, techniques for\nlocating them, and potential countermeasures for the interferences they produce in pharmaceutical\nanalysis. Antiviral medications are a class of medications used to treat viral infections. They\nwork by preventing the growth of the pathogen they are intended to treat. Drugs that target viral\nactivities must enter host cells because viruses are obligatory intracellular entities and prevent\nthe production of viral DNA, which is subsequently converted to triphosphate. Regulatory authorities\nnow need not just purity profiles but also impurity profiles. This review also covers the\norigins of impurities, how they are classified, and the different analytical techniques used to\nidentify and quantify them. It also covers the simple, rapid, accurate, precise, and exact creation\nof innovative analytical techniques for determining impurity levels.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0125899775331541250226065837","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T03:59:16Z","timestamp":1741319956000},"page":"394-411","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Significance of Impurity Analysis in Antiviral Drug: A Critical Review"],"prefix":"10.2174","volume":"17","author":[{"given":"Balaji","family":"Ramakrishnan","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research,\nOoty, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyaprakash Mari","family":"Raju","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher\nEducation and Research, Ooty, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabha","family":"Thangavelu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Nandha College of\nPharmacy, Affiliated to The Tamil Nadu Dr. MGR Medical University-Chennai, Erode, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esakkimuthukumar","family":"Mariappan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research,\nOoty, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawahar","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-6621","authenticated-orcid":true,"given":"Jubie","family":"Selvaraj","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research,\nOoty, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"254","volume":"6","author":"Venkatesan P.","year":"2014","unstructured":"Venkatesan P.; Valliappan K.; Impurity profiling: Theory and practice. J Pharm Sci Res  2014,6(7),254","journal-title":"J Pharm Sci Res"},{"key":"ref=2","first-page":"e87","volume":"9","author":"Poojashree P.","year":"2019","unstructured":"Poojashree P.; Pramila T.; Kumar S.M.; Kumar S.G.P.; A review on pharmaceutical impurities and its importance in pharmacy. Am J Pharmtech Res  2019,9(76),e87","journal-title":"Am J Pharmtech Res"},{"key":"ref=3","first-page":"3958603","author":"Shaikh T.","year":"2019","unstructured":"Shaikh T.; Impurities characterization in pharmaceuticals: A review. SSRN  Available from:  https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=39586032019,3958603","journal-title":"SSRN"},{"key":"ref=4","first-page":"3603","volume":"3","author":"Shah S.R.","year":"2012","unstructured":"Shah S.R.; Patel M.A.; Naik M.V.; Pradhan P.K.; Upadhyay U.M.; Recent approches of&#x201D; impurity profiling&#x201D; in pharmaceutical analysis: A review. Int J Pharm Sci Res  2012,3(10),3603","journal-title":"Int J Pharm Sci Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4103\/0110-5558.72422","volume":"1","author":"Chandrawanshi H.K.","year":"2010","unstructured":"Chandrawanshi H.K.; Pilaniya K.; Pilaniya U.; Manchandani P.; Jain P.; Singh N.; Recent trends in the impurity profile of pharmaceuticals. J Adv Pharm Technol Res  2010,1(3),302-310","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=6","year":"2024","unstructured":"ICH Q3A (R2) Impurities in new drug substances - Scientific guideline | European Medicines Agency.  Available from:  https:\/\/www.ema.europa.eu\/en\/ich-q3a-r2-impurities-new-drug-substances-scientific-guideline [cited 2024 May 13].2024"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.22270\/ajprd.v10i2.1052","volume":"10","year":"2022","unstructured":"Impurity profiling: A review. Asian J Pharma Res Deve B BA, M KK 2022,10(2),135-143","journal-title":"Asian J Pharma Res Deve"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5530\/ijpi.14.2.37","volume":"14","author":"Dsouza S.J.","year":"2024","unstructured":"Dsouza S.J.; Sandeep D.S.; Charyulu R.N.; Gowrav M.P.; Pradeep H.K.; Impurities in drug substance-an overview of ICH Q3A, Q3C and M7 guidelines. Int J Pharm Investig  [Internet].2024,14(2),299-305","journal-title":"Int J Pharm Investig"},{"key":"ref=9","first-page":"1","volume":"4","author":"Guideline IHT","year":"2006","unstructured":"Guideline IHT; Impurities in new drug products. Q3B R2 Curr Step  2006,4,1-5","journal-title":"Q3B R2 Curr Step"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1515\/revac-2014-0001","volume":"33","author":"Prajapati P.","year":"2014","unstructured":"Prajapati P.; Agrawal Y.K.; Analysis and impurity identification in pharmaceuticals. Rev Anal Chem  2014,33(2),123-133","journal-title":"Rev Anal Chem"},{"key":"ref=11","first-page":"190","volume":"3","author":"Saibaba S.V.","year":"2016","unstructured":"Saibaba S.V.; Kumar M.S.; Ramu B.; Pharmaceutical impurities and their characterization: A review. Eur J Pharm Med Res  2016,3(5),190-196","journal-title":"Eur J Pharm Med Res"},{"key":"ref=12","author":"Kar A.","year":"2005","unstructured":"Kar A.; Pharmaceutical drug analysis. New Age International  Available from:  https:\/\/books.google.com\/books?hl=enandlr=andid=nnNfLesNzLoCandoi=fndandpg=PR7anddq=enumeration+of+impurities+in+drugsandots=OeU6sE0GD_andsig=ZM9H_nWAwBKGyW8RztA0xmvSfQI [cited 2024 Dec 14].2005","journal-title":"New Age International"},{"key":"ref=13","first-page":"232","volume":"5","author":"Misra B.","year":"2015","unstructured":"Misra B.; Thakur A.; Mahata P.P.; Pharmaceutical impurities: A review. Int J Pharm Chem  2015,5(7),232-239","journal-title":"Int J Pharm Chem"},{"key":"ref=14","first-page":"70","volume":"4","author":"Alsante K.M.","year":"2001","unstructured":"Alsante K.M.; Hatajik T.D.; Lohr L.L.; Sharp T.R.; Isolation and identification of process related impurities and degradation products from pharmaceutical drug candidates, Part I. Am Pharm Rev  2001,4,70-78","journal-title":"Am Pharm Rev"},{"key":"ref=15","author":"Grodowska K","unstructured":"Grodowska K; Parczewski A; Analytical methods for residual solvents determination in pharmaceutical products 2010."},{"key":"ref=16","volume":"6","author":"Bhavyasri K.","year":"2019","unstructured":"Bhavyasri K.; Vishnumurthy K.M.; Rambabu D.; Sumakanth M.; ICH guidelines\u2013&#x201C;Q&#x201D; series (quality guidelines)-A review. GSC Biol Pharm Sci  2019,6(3)","journal-title":"GSC Biol Pharm Sci"},{"key":"ref=17","first-page":"1337","volume":"6","author":"Singh A.","year":"2017","unstructured":"Singh A.; Afreen S.; Singh D.P.; Kumar R.; A review on pharmaceutical impurities and their importance. World J Pharm Pharm Sci  2017,6(10),1337-1354","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/10408347.2016.1169913","volume":"47","author":"Ramachandra B.","year":"2017","unstructured":"Ramachandra B.; Development of impurity profiling methods using modern analytical techniques. Crit Rev Anal Chem  2017,47(1),24-36","journal-title":"Crit Rev Anal Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cca.2019.01.023","volume":"491","author":"Zheng Y.Z.","year":"2019","unstructured":"Zheng Y.Z.; Wang S.; Advances in antifungal drug measurement by liquid chromatography-mass spectrometry. Clin Chim Acta  2019,491,132-145","journal-title":"Clin Chim Acta"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1451A","DOI":"10.1021\/ac00127a001","volume":"58","author":"Covey T.R.","year":"1986","unstructured":"Covey T.R.; Lee E.D.; Bruins A.P.; Henion J.D.; Liquid chromatography\/mass spectrometry. Anal Chem  1986,58(14),1451A-1461A","journal-title":"Anal Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s11270-012-1410-3","volume":"224","author":"Jain S.","year":"2013","unstructured":"Jain S.; Kumar P.; Vyas R.K.; Pandit P.; Dalai A.K.; Occurrence and removal of antiviral drugs in environment: A review. Water Air Soil Pollut  2013,224(2),1410","journal-title":"Water Air Soil Pollut"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cca.2009.06.023","volume":"407","author":"Waterval W.A.H.","year":"2009","unstructured":"Waterval W.A.H.; Scheijen J.L.J.M.; Ortmans-Ploemen M.M.J.C.; Habets-van der Poel C.D.; Bierau J.; Quantitative UPLC-MS\/MS analysis of underivatised amino acids in body fluids is a reliable tool for the diagnosis and follow-up of patients with inborn errors of metabolism. Clin Chim Acta  2009,407(1-2),36-42","journal-title":"Clin Chim Acta"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408347.2024.2384046","author":"Cordeiro F.C.","year":"2024","unstructured":"Cordeiro F.C.; Franco L.L.; Carvalho T.D.; Bonfilio R.; Impurities in active pharmaceutical ingredients and drug products: A critical review. Crit Rev Anal Chem  2024,1-21","journal-title":"Crit Rev Anal Chem"},{"key":"ref=24","first-page":"49","volume":"3","author":"Suneetha A.","year":"2011","unstructured":"Suneetha A.; Kathirvel S.; Ramachandrika G.; A validated RP HPLC method for simultaneous estimation of lopinavir and ritonavir in combined dosage form. Int J Pharm Pharm Sci  2011,3(1),49-51","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3797\/scipharm.1403-20","volume":"82","author":"Katakam P.","year":"2014","unstructured":"Katakam P.; Dey B.; Hwisa N.T.; An experimental design approach for impurity profiling of valacyclovir-related products by RP-HPLC. Sci Pharm  2014,82(3),617-630","journal-title":"Sci Pharm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/284652","volume":"2014","author":"Muralidharan S.","year":"2014","unstructured":"Muralidharan S.; Kalaimani J.; Parasuraman S.; Dhanaraj S.A.; Development and validation of acyclovir hplc external standard method in human plasma: Application to pharmacokinetic studies. Advances in Pharmaceutics  2014,2014,1-5","journal-title":"Advances in Pharmaceutics"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"116108","DOI":"10.1016\/j.trac.2020.116108","volume":"134","author":"Santana-Mayor\u00c1.","year":"2021","unstructured":"Santana-Mayor\u00c1.; Rodr&#xED;guez-Ramos R.; Herrera-Herrera A.V.; Socas-Rodr&#xED;guez B.; Rodr&#xED;guez-Delgado M.&#xC1;.; Deep eutectic solvents. The new generation of green solvents in analytical chemistry. Trends Analyt Chem  2021,134,116108","journal-title":"Trends Analyt Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.trac.2018.10.022","volume":"111","author":"Kurowska-Susdorf A.","year":"2019","unstructured":"Kurowska-Susdorf A.; Zwier&#x17C;d&#x17C;y\u0144ski M.; Bevanda A.M.; Tali\u0107 S.; Ivankovi\u0107 A.; P\u0142otka-Wasylka J.; Green analytical chemistry: Social dimension and teaching. Trends Analyt Chem  2019,111,185-196","journal-title":"Trends Analyt Chem"},{"key":"ref=29","author":"Guardia D.L.M.","year":"2010","unstructured":"Guardia D.L.M.; Armenta S.; Green analytical chemistry. Theory and practice  2010","journal-title":"Theory and practice"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.22270\/jddt.v11i1-s.4515","volume":"11","author":"Sharma S.","year":"2021","unstructured":"Sharma S.; Singh N.; Ankalgi A.D.; Rana A.; Ashawat M.S.; Modern trends in analytical techniques for method development and validation of pharmaceuticals: A review. J Drug Deliv Ther  2021,11(1-s),121-130","journal-title":"J Drug Deliv Ther"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.46624\/ajptr.2019.v9.i2.010","volume":"9","author":"Phadke R.","year":"2019","unstructured":"Phadke R.; Mali R.; Mundhe A.; Gosar A.; Drug Impurity profiling an emerging task to Pharmaceutical Industries now days - A Review. Amer J PharmTech Res  2019,9(2),94-111","journal-title":"Amer J PharmTech Res"},{"key":"ref=32","first-page":"1","author":"Hamilton R.J.","year":"1982","unstructured":"Hamilton R.J.; Sewell P.A.;  Introduction to high performance liquid chromatographyIntroduction to high performance liquid chromatography  [Internet].1982,1-12","journal-title":"Introduction to high performance liquid chromatographyIntroduction to high performance liquid chromatography"},{"key":"ref=33","author":"Lough W.J.","year":"1995","unstructured":"Lough W.J.; Wainer I.W.;  High performance liquid chromatography: Fundamental principles and practice  Available from:  https:\/\/books.google.com\/books?hl=enandlr=andid=9SzJGAmWIvMCandoi=fndandpg=PA1anddq=%09High-Performance+Liquid+Chromatographyandots=pvOJHivtcRandsig=-JAsNAiyxaZ6tN59_mtgRL1JNFs1995","journal-title":"High performance liquid chromatography: Fundamental principles and practice"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/humu.1130","volume":"17","author":"Xiao W.","year":"2001","unstructured":"Xiao W.; Oefner P.J.; Denaturing high-performance liquid chromatography: A review. Hum Mutat  2001,17(6),439-474","journal-title":"Hum Mutat"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1016\/j.chroma.2011.05.102","volume":"1218","author":"Debrus B.","year":"2011","unstructured":"Debrus B.; Lebrun P.; Kindenge J.M.; Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space. J Chromatogr A  2011,1218(31),5205-5215","journal-title":"J Chromatogr A"},{"key":"ref=36","first-page":"243","volume":"1","author":"Patil M.P.N.","year":"2017","unstructured":"Patil M.P.N.; HPLC Method Development\u2013A Review. J Pharm Res Educ  2017,1(2),243-260","journal-title":"J Pharm Res Educ"},{"key":"ref=37","first-page":"78","volume":"3","author":"Murugan S.","year":"2013","unstructured":"Murugan S.; Elayaraja A.; Chandrakala K.; Ramaiah P.; Vulchi C.; A review on method development and validation by using HPLC. Int J Novel Trends Pharm Sci  2013,3(4),78-81","journal-title":"Int J Novel Trends Pharm Sci"},{"key":"ref=38","first-page":"8","volume":"6","author":"Patwekar S.L.","year":"2015","unstructured":"Patwekar S.L.; Sakhare R.S.; Nalbalwar N.N.; HPLC method development and validation-A general Concept. Int J Chem Pharm Sci  2015,6(1),8-14","journal-title":"Int J Chem Pharm Sci"},{"key":"ref=39","first-page":"76","volume":"5","author":"Bhardwaj S.K.","year":"2015","unstructured":"Bhardwaj S.K.; Dwivedia K.; Agarwala D.D.; A review: HPLC method development and validation. Int J Anal Bioanal Chem  2015,5(4),76-81","journal-title":"Int J Anal Bioanal Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"20587384211002621","DOI":"10.1177\/20587384211002621","volume":"35","author":"Kausar S.","year":"2021","unstructured":"Kausar S.; Khan S.F.; Ishaq Mujeeb Ur Rehman M.; A review: Mechanism of action of antiviral drugs. Int J Immunopathol Pharmacol  2021,35,20587384211002621","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4103\/ijp.ijp_291_22","volume":"54","author":"Niraj N.","year":"2022","unstructured":"Niraj N.; Mahajan S.S.; Prakash A.; Sarma P.; Medhi B.; Paxlovid. Indian J Pharmacol  2022,54(6),452-458","journal-title":"Indian J Pharmacol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"13224","DOI":"10.1039\/D3RA00654A","volume":"13","author":"Khalil H.A.","year":"2023","unstructured":"Khalil H.A.; Hassanein N.A.; El-Yazbi A.F.; Recent analytical methodologies for the determination of anti-covid-19 drug therapies in various matrices: A critical review. RSC Advances  2023,13(19),13224-13239","journal-title":"RSC Advances"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41598-022-26944-y","volume":"13","author":"Imam M.S.","year":"2023","unstructured":"Imam M.S.; Batubara A.S.; Gamal M.; Abdelazim A.H.; Almrasy A.A.; Ramzy S.; Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations. Sci Rep  2023,13(1),137","journal-title":"Sci Rep"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"105069","DOI":"10.1016\/j.microc.2020.105069","volume":"157","author":"Rashed N.S.","year":"2020","unstructured":"Rashed N.S.; Zayed S.; Abdelazeem A.; Fouad F.; Development and validation of a green HPLC method for the analysis of clorsulon, albendazole, triclabendazole and ivermectin using monolithic column: Assessment of the greenness of the proposed method. Microchem J  2020,157,105069","journal-title":"Microchem J"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1039\/D3RE00019B","volume":"8","author":"Jiang B.","year":"2023","unstructured":"Jiang B.; Li G.; Yu J.; Synthesis and crystal characteristics of nirmatrelvir. React Chem Eng  2023,8(7),1747-1759","journal-title":"React Chem Eng"},{"key":"ref=46","first-page":"2932","volume":"4","author":"Bari S.","year":"2015","unstructured":"Bari S.; Jain P.S.; Shirkhedkar A.A.; Sonawane L.V.; Mhaske A.J.; Gawad J.B.; Impurities in pharmaceuticals: A review. World J Pharm Res  2015,4(10),2932-2947","journal-title":"World J Pharm Res"},{"key":"ref=47","first-page":"174","volume":"2","author":"Tegeli V.S.","year":"2011","unstructured":"Tegeli V.S.; Gajeli G.B.; Chougule G.K.; Thorat Y.S.; Shivsharan U.S.; Kumbhar S.T.; Significance of impurity profiling: A Review. Int J Drug Formul Res  2011,2(4),174-195","journal-title":"Int J Drug Formul Res"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0125899775331541250226065837","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/240005\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0125899775331541250226065837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T11:47:26Z","timestamp":1758023246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/240005\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0125899775331541250226065837","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}